About LabNow
LabNow is a company based in Austin (United States) founded in 2005. It operates as a B2B. LabNow has raised $21.64 million across 5 funding rounds from investors including Sammons and Austin Technology Incubator. LabNow operates in a competitive market with competitors including Chembio, Cellavision, Diatron, MicroX Labs and Sedia Biosciences, among others.
- Headquarter Austin, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$21.64 M (USD)
in 5 rounds
-
Latest Funding Round
$605 K (USD), Series B
May 11, 2010
-
Investors
Sammons
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of LabNow
LabNow has successfully raised a total of $21.64M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $605 thousand completed in May 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LabNow
LabNow has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Sammons and Austin Technology Incubator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep tech commercialization is facilitated by Austin Technology Incubator.
|
Locked | Locked | Locked | |
|
Investments are directed toward consumer products and B2B services.
|
Locked | Locked | Locked |
Investor details for LabNow
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LabNow
Investment portfolio details for LabNow
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LabNow
Detailed financials for LabNow
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Labnow Comparisons
Peer comparison for LabNow
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LabNow
LabNow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chembio, Cellavision, Diatron, MicroX Labs and Sedia Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary immunoassay platform is utilized for infectious disease diagnostics.
|
|
| Locked | Locked | Locked |
Solutions for digital microscopy.
|
|
| Locked | Locked | Locked |
Hematology and clinical chemistry analyzers with reagents are manufactured.
|
|
| Locked | Locked | Locked |
MEMS-based biochips are developed for blood cell counting.
|
|
| Locked | Locked | Locked |
Point-of-care HIV diagnostic assays and surveillance tools are developed.
|
|
| Locked | Locked | Locked |
Diagnostic tools for infectious diseases are developed using genotyping platforms.
|
Detailed competitors of LabNow
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Labnow
Complete news archive for LabNow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LabNow
LabNow was founded in 2005 and raised its 1st funding round 1 year after it was founded.
LabNow is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
LabNow is a funded company, having raised a total of $21.64M across 5 funding rounds to date.
LabNow, established in 2005 and currently in Dissolved stage, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and point-of-care systems. Offers WBC counting point-of-care diagnostic systems for healthcare needs. Adapting to market demands with innovation and client-focused strategies.
LabNow's top competitors include Cellavision, Chembio and MicroX Labs.
LabNow has 2 investors. Key investors include Sammons, and Austin Technology Incubator.